PTEN and neoplasm: Both sources efficiently delivered miR‐93‐5p to NSCLC cells, leading to PTEN suppression, reduced PTEN‐3′ UTR activity, and enhanced tumor aggressiveness, all of which were reversed by ASO‐miR‐93‐5p.